These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 25193162)
41. Accelerated sonothrombolysis with Definity in a xenographic porcine cerebral thromboembolism model. Kleven RT; Karani KB; Hilvert N; Ford SM; Mercado-Shekhar KP; Racadio JM; Rao MB; Abruzzo TA; Holland CK Sci Rep; 2021 Feb; 11(1):3987. PubMed ID: 33597659 [TBL] [Abstract][Full Text] [Related]
42. The effect of anticonvulsant drugs on the fibrinolytic activity of tissue plasminogen activator. Zemke D; Farooq MU; Gupta R; Kassab M; Reeves M; Majid A Cerebrovasc Dis; 2008; 25(1-2):107-10. PubMed ID: 18057880 [TBL] [Abstract][Full Text] [Related]
43. Comparative lytic efficacy of rt-PA and ultrasound in porcine versus human clots. Huang S; Shekhar H; Holland CK PLoS One; 2017; 12(5):e0177786. PubMed ID: 28545055 [TBL] [Abstract][Full Text] [Related]
44. Effect of Clot Stiffness on Recombinant Tissue Plasminogen Activator Lytic Susceptibility in Vitro. Mercado-Shekhar KP; Kleven RT; Aponte Rivera H; Lewis R; Karani KB; Vos HJ; Abruzzo TA; Haworth KJ; Holland CK Ultrasound Med Biol; 2018 Dec; 44(12):2710-2727. PubMed ID: 30268531 [TBL] [Abstract][Full Text] [Related]
48. Comparison of local thrombolytic efficacy of plasmin and rt-PA in an in-vitro flow system; a pilot study. Bizjak N; Bajd F; Vidmar J; Blinc A; Marder VJ; Novokhatny V; Serša I Blood Coagul Fibrinolysis; 2013 Oct; 24(7):711-4. PubMed ID: 23751605 [TBL] [Abstract][Full Text] [Related]
49. Combination of ultrasound and rtPA enhances fibrinolysis in an In Vitro clot system. Masomi-Bornwasser J; Winter P; Müller-Werkmeister H; Strand S; König J; Kempski O; Ringel F; Kantelhardt SR; Giese A; Keric N PLoS One; 2017; 12(11):e0188131. PubMed ID: 29145482 [TBL] [Abstract][Full Text] [Related]
50. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890 [TBL] [Abstract][Full Text] [Related]
51. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro. Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946 [TBL] [Abstract][Full Text] [Related]
52. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening. Kostka B; Para J; Sikora J Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947 [TBL] [Abstract][Full Text] [Related]
53. The spatial dynamics of fibrin clot dissolution catalyzed by erythrocyte-bound vs. free fibrinolytics. Gersh KC; Zaitsev S; Muzykantov V; Cines DB; Weisel JW J Thromb Haemost; 2010 May; 8(5):1066-74. PubMed ID: 20149071 [TBL] [Abstract][Full Text] [Related]
54. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935). Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138 [TBL] [Abstract][Full Text] [Related]
55. An In Vitro Assay for Sonothrombolysis Based on the Spectrophotometric Measurement of Clot Thickness. Wang Z; Sawaguchi Y; Hirose H; Ohara K; Sakamoto S; Mitsumura H; Ogawa T; Iguchi Y; Yokoyama M J Ultrasound Med; 2017 Apr; 36(4):681-698. PubMed ID: 28150461 [TBL] [Abstract][Full Text] [Related]
56. Clot retraction affects the extent of ultrasound-enhanced thrombolysis in an ex vivo porcine thrombosis model. Sutton JT; Ivancevich NM; Perrin SR; Vela DC; Holland CK Ultrasound Med Biol; 2013 May; 39(5):813-24. PubMed ID: 23453629 [TBL] [Abstract][Full Text] [Related]
57. In-vitro sonothrombolysis using thick-shelled polymer microbubbles - a comparison with thin-shelled microbubbles. Janjic J; Larsson MK; Bjällmark A Cardiovasc Ultrasound; 2020 May; 18(1):12. PubMed ID: 32366318 [TBL] [Abstract][Full Text] [Related]
58. Altered lysis resistance of platelet-rich clots in patients with insulin-dependent diabetes mellitus. Udvardy M; Posan E; Harsfalvi J Thromb Res; 1995 Jul; 79(1):57-63. PubMed ID: 7495104 [TBL] [Abstract][Full Text] [Related]
59. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Francis CW; Blinc A; Lee S; Cox C Ultrasound Med Biol; 1995; 21(3):419-24. PubMed ID: 7645133 [TBL] [Abstract][Full Text] [Related]
60. Improved mechanical thrombolysis with the addition of recombinant tissue-type plasminogen activator: in vitro study with use of Cr-51-labeled clots. Kurisu Y; Kawakami K; Tada S J Vasc Interv Radiol; 1994; 5(6):877-80. PubMed ID: 7873868 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]